Industry-sponsored

Continuing Review (Expedited Review)    SGD350 (subject to prevailing GST)

PI-Initiated

Continuing Review (Expedited Review)    SGD200 (subject to prevailing GST)

If you are interested to have a one-to-one networking session with us during the convention, please feel free to contact our Business Development Assistant – Ms. Sherleen Lim at sherleen_lim@gleneaglescrc.com or +65-6349 8001.

We look forward to meeting you at this convention!

 - Annex H – Indemnity Form

- PIEC UPIRTSO Reporting Table Form (Overseas) 

These updated forms are effective 20 July 2011. However, the PIEC will be giving applicants up to one month to adapt to these forms. All submissions to PIEC from 20 August 2011 onwards should be using the latest forms.

 You may refer to here for the PIEC forms.

 Please feel free to contact PIEC Secretariat at 6737 3642 or piec@gleneaglescrc.com for further information.

This year, GCP Workshop would be conducted on 30 Nov – 1 Dec 2011 at Shangri-La Hotel, Jakarta, Indonesia.

Within this 2-days GCP Workshop, you will be exposed to the theoretical and operational aspects of core Clinical Trials Management activities. We believe that it is important that participants will put what they are learning to use, and they will be evaluated on their knowledge through a GCP Test.

Participant who pass the test will receive a certificate exclusively issued by GleneaglesCRC Pte Ltd.

So, come on and wait no more…!!! Sign up your self into this precious workshop..

Should you need further info and detailed agenda, please feel free to conctact “Mr. Febri” at +62-21-5207739 or febri_dl@gleneaglescrc.com.

Agenda GCP-Workshop 2011

These updated and new forms are effective on 01 Mar 2011. However, the PIEC will be giving applicants up to one month to adapt to these forms. All submissions to PIEC from 01 Apr 2011 onwards should be using the latest forms.

You may refer to here for the PIEC forms.

Please feel free to contact PIEC Secretariat at 6737 3642 or piec@gleneaglescrc.com for further information.

Speakers on the GCP-Workshop.

Participants during Group Exercises and Discussion:

See you in the next GCP-Workshop on 1-2 Dec 2010 in Shangri-La Hotel, Jakarta, Indonesia..

This year, GCP Workshop would be conducted on 1-2 December 2010 at Shangri-La Hotel, Jakarta, Indonesia.

Within this 2-days GCP Workshop, you will be exposed to the theoretical and operational aspects of core Clinical Trials Management activities. We believe that it is important that participants will put what they are learning to use, and they will be evaluated on their knowledge through a GCP Test.

Participant who pass the test will receive a certificate exclusively issued by GleneaglesCRC Pte Ltd and being endorsed by Murdoch University, Western Australia.

So, come on and wait no more…!!! Sign up your self into this precious workshop..

Should you need further info and detailed agenda, please feel free to conctact “Mr. Deny” at +62-21-5207739 or deny_l@gleneaglescrc.com.

Flyer GCP-Workshop 2010 (27Oct2010)

SEVCTC its self, designated by the Korean Ministry of Health and WElface in 2005 as a Regional Clinical Trials Centre, and was granted the government fund for its establishment and operations, in addition to the contribution from Seoul City and 9 pharmaceutical companies.

Under the terms of the MOU, GCRC and SEVCTC intend to enter into a mutually beneficial cooperative relationship to provide comprehensive and high quality clinical research services to global pharmaceutical and biopharmaceutical companies. Both parties will embark on joint marketing efforts to promote each other’s services to these companies; SEVCTC will be GCRC’s preferred subcontractor for clinical research that are required to be conducted in South Korea, while GCRC will be SEVCTC’s preferred subcontractor for clinical research studies to be conducted in the Asia-Pacific region.

The ultimate goal of the centre is to improve medical care for the patients through enhancement of world-class quality clinical research activities. The centre aims to lead new drug development globally as well as domestically in collaboration with industry and regulatory bodies. It also ensures that the clinical studies are done in the most ethical and scientifically sounds ways to protect rights, safety and welfare of study participants.

Memorandum of Understanding (MOU) had been signed between GleneaglesCRC Pte Ltd (GCRC) and Clinical Trial Centre of Severance Hospital, Yonsei University Health System (SEVCTC) in South Korea.

SEVCTC its self, designated by the Korean Ministry of Health and WElface in 2005 as a Regional Clinical Trials Centre, and was granted the government fund for its establishment and operations, in addition to the contribution from Seoul City and 9 pharmaceutical companies.

Under the terms of the MOU, GCRC and SEVCTC intend to enter into a mutually beneficial cooperative relationship to provide comprehensive and high quality clinical research services to global pharmaceutical and biopharmaceutical companies. Both parties will embark on joint marketing efforts to promote each other’s services to these companies; SEVCTC will be GCRC’s preferred subcontractor for clinical research that are required to be conducted in South Korea, while GCRC will be SEVCTC’s preferred subcontractor for clinical research studies to be conducted in the Asia-Pacific region.

The ultimate goal of the centre is to improve medical care for the patients through enhancement of world-class quality clinical research activities. The centre aims to lead new drug development globally as well as domestically in collaboration with industry and regulatory bodies. It also ensures that the clinical studies are done in the most ethical and scientifically sounds ways to protect rights, safety and welfare of study participants.

You may download the form from here.
Please feel free to contact PIEC Secretariat at 6737 3642 or piec@gleneaglescrc.com for further information.